BETR — BetterLife Pharma Balance Sheet
0.000.00%
- CA$12.95m
- CA$17.13m
Annual balance sheet for BetterLife Pharma, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 2.68 | 0.155 | 0.174 | 0.008 | 0.037 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.137 | 0.52 | 0.325 | 0.017 | 0.04 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.48 | 1.33 | 1.14 | 0.075 | 0.325 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.79 | 0.037 | 0.018 | 0 | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 8.25 | 1.37 | 1.16 | 0.075 | 0.325 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.96 | 5.85 | 4.14 | 7.15 | 6.83 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.59 | 5.98 | 5.04 | 10.8 | 11.1 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.66 | -4.61 | -3.88 | -10.7 | -10.8 |
Total Liabilities & Shareholders' Equity | 8.25 | 1.37 | 1.16 | 0.075 | 0.325 |
Total Common Shares Outstanding |